Helsinn Group

www.helsinn.com

PO Box 357
Pambio-Noranco
Lugano
CH-6915
Switzerland

+41 91 985 21 21

Activities

Design & Build | HVAC | Research & Development | Analysis

Related Companies

Related Content

Helsinn signs distribution agreement with Immedica Pharma
Helsinn signs distribution agreement with Immedica Pharma
Helsinn brings cancer pain management option to China
Helsinn brings cancer pain management option to China
Helsinn invests €1 million in Gain Therapeutics
Helsinn invests €1 million in Gain Therapeutics
Approval of AKYNZEO oral formulation in Korea
Approval of AKYNZEO oral formulation in Korea
Helsinn and the Scientific Centre of Monaco collaborate
Helsinn and the Scientific Centre of Monaco collaborate
Orphan drug designation for AML treatment
Orphan drug designation for AML treatment
Helsinn Pharmaceuticals opens office in Shanghai, China
Helsinn Pharmaceuticals opens office in Shanghai, China
Helsinn Investment Fund leads financial round in GreenBone
Helsinn Investment Fund leads financial round in GreenBone
Helsinn appoints Eric Cornut to Board of Directors
Helsinn appoints Eric Cornut to Board of Directors
Patent battle for Aloxi in the US
Patent battle for Aloxi in the US
Patient-driven innovations for cancer sufferers
Patient-driven innovations for cancer sufferers
Helsinn Group and MEI Pharma to develop acute myeloid leukaemia treatment
Helsinn Group and MEI Pharma to develop acute myeloid leukaemia treatment
Latest EU drug approvals span range of health issues
Latest EU drug approvals span range of health issues
Antiemetic – netupitant
Antiemetic – netupitant
Cancer anorexia–cachexia – anamorelin
Cancer anorexia–cachexia – anamorelin